Figures & data
Notes: (A) EQ-5D scores by treatment cohorts. (B) EQ-VAS scores by treatment cohorts. P<0.05 for all comparisons between the duloxetine cohort and the SSRI cohort at each postbaseline visit. aThe baseline scores are raw mean values.
Abbreviations: SSRI, selective serotonin reuptake inhibitor; QoL, quality of life; EQ-5D, EuroQoL-5 Dimensions; EQ-VAS, EuroQoL-Visual Analog Scale.
Abbreviations: SSRI, selective serotonin reuptake inhibitor; QoL, quality of life; EQ-5D, EuroQoL-5 Dimensions; EQ-VAS, EuroQoL-Visual Analog Scale.
Notes: (A) EQ-5D scores by treatment cohorts. (B) EQ-VAS scores by treatment cohorts. P<0.05 for all comparisons between the duloxetine cohort and the SSRI cohort at 24 weeks in both PPS+ and PPS− patients, respectively. aThe baseline scores are raw mean values.
Abbreviations: PPS, painful physical symptoms; SSRI, selective serotonin reuptake inhibitor; QoL, quality of life; EQ-5D, EuroQoL-5 Dimensions; EQ-VAS, EuroQoL-Visual Analog Scale.
Abbreviations: PPS, painful physical symptoms; SSRI, selective serotonin reuptake inhibitor; QoL, quality of life; EQ-5D, EuroQoL-5 Dimensions; EQ-VAS, EuroQoL-Visual Analog Scale.